the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
Official Title An Open-Label Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
Principal Investigator Nanda, Rita
Brief Summary This is a multicenter, open-label study in participants with triple negative breast cancer (TNBC) to study the safety, tolerability, pharmacokinetics and preliminary efficacy of SC-005. This study consists of 2 parts: Part A (dose regimen finding) followed by Part B (dose expansion).
Gender All
Ages 18 Years
Enrollment 108
Accepts Healthy Volunteers Accepts Healthy Volunteers
Lead Sponsor AbbVieIndustry
Collaborator
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Cancer - Breast
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI